{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:22:40Z","timestamp":1787552560812,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773112"],"award-info":[{"award-number":["81773112"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073186"],"award-info":[{"award-number":["82073186"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Autophagy is controlled by a complex signalling network and is closely linked to the initiation and progression of hepatocellular carcinoma (HCC). However, how microRNAs (miRNAs) regulate autophagy in HCC remains incompletely understood. In this study, we identified microRNA-486-5p (miR-486-5p) as a tumour-associated microRNA that is enriched in circulating exosomes derived from patients with HCC. Elevated miR-486-5p promoted proliferation and suppressed apoptosis in HCC cell lines under stress conditions. Mechanistically, miR-486-5p directly targets the 3\u2032 untranslated region of the phosphatase and tensin homologue (\n                    <jats:italic>PTEN<\/jats:italic>\n                    ) gene, thereby decreasing the production of the PTEN protein and consequently leading to the activation of the protein kinase B (AKT)\/mammalian target of rapamycin (mTOR) signalling pathway. This phenomenon was accompanied by the inhibitory phosphorylation of unc-51\u00a0like autophagy-activating kinase 1 (ULK1), which resulted in impaired autophagy. The pharmacological inhibition of AKT or mTOR led to the restoration of autophagy and the attenuation of miR-486-5p-driven growth and survival advantages. Furthermore, the transcription factor MYB was found to bind the promoter of\n                    <jats:italic>ankyrin-1<\/jats:italic>\n                    (\n                    <jats:italic>ANK1<\/jats:italic>\n                    ), the host gene of miR-486-5p, and to drive its expression. In an orthotopic liver tumour model, the liver-targeted delivery of miR-486-5p accelerated tumour expansion, an effect that was reversed by AKT or mTOR blockade. Collectively, these findings delineate a MYB\/miR-486-5p\/PTEN\/AKT\/mTOR signalling axis that constrains autophagy to facilitate HCC progression, suggesting potential avenues for biomarker development and therapeutic intervention.\n                  <\/jats:p>","DOI":"10.1186\/s43556-026-00556-8","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:15:10Z","timestamp":1787552110000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["miR-486-5p suppresses autophagy in hepatocellular carcinoma via activation of the AKT\/mTOR signalling pathway"],"prefix":"10.1186","volume":"7","author":[{"given":"Yazheng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjin","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2715-0087","authenticated-orcid":false,"given":"Qiyu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"issue":"8","key":"556_CR1","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","volume":"24","author":"J Debnath","year":"2023","unstructured":"Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24(8):560\u201375. https:\/\/doi.org\/10.1038\/s41580-023-00585-z.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"556_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216744","volume":"588","author":"G Wang","year":"2024","unstructured":"Wang G, Jiang X, Torabian P, Yang Z. Investigating autophagy and intricate cellular mechanisms in hepatocellular carcinoma: emphasis on cell death mechanism crosstalk. Cancer Lett. 2024;588:216744. https:\/\/doi.org\/10.1016\/j.canlet.2024.216744.","journal-title":"Cancer Lett"},{"issue":"7806","key":"556_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41586-020-2229-5","volume":"581","author":"K Yamamoto","year":"2020","unstructured":"Yamamoto K, Venida A, Yano J, Biancur DE, Kakiuchi M, Gupta S, et al. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature. 2020;581(7806):100\u20135. https:\/\/doi.org\/10.1038\/s41586-020-2229-5.","journal-title":"Nature"},{"key":"556_CR4","doi-asserted-by":"publisher","unstructured":"Wang J, Xie Q, Wu L, Zhou Y, Xu Y, Chen Y, et al. Stromal interaction molecule 1\/microtubule-associated protein 1A\/1B-light chain 3B complex induces metastasis of hepatocellular carcinoma by promoting autophagy. MedComm (2020). 2024;5(2):e482. https:\/\/doi.org\/10.1002\/mco2.482.","DOI":"10.1002\/mco2.482"},{"issue":"6","key":"556_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.104723","volume":"299","author":"C Zeng","year":"2023","unstructured":"Zeng C, Guo J, Wu J, Che T, Huang X, Liu H, et al. HRD1 promotes non-small cell lung carcinoma metastasis by blocking autophagy-mediated MIEN1 degradation. J Biol Chem. 2023;299(6):104723. https:\/\/doi.org\/10.1016\/j.jbc.2023.104723.","journal-title":"J Biol Chem"},{"issue":"3","key":"556_CR6","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.jhep.2021.10.014","volume":"76","author":"X Chao","year":"2022","unstructured":"Chao X, Wang S, Fulte S, Ma X, Ahamed F, Cui W, et al. Hepatocytic p62 suppresses ductular reaction and tumorigenesis in mouse livers with mTORC1 activation and defective autophagy. J Hepatol. 2022;76(3):639\u201351. https:\/\/doi.org\/10.1016\/j.jhep.2021.10.014.","journal-title":"J Hepatol"},{"key":"556_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217161","volume":"600","author":"M Lu","year":"2024","unstructured":"Lu M, Gong X, Zhang YM, Guo YW, Zhu Y, Zeng XB, et al. Platelets promote primary hepatocellular carcinoma metastasis through TGF-beta1-mediated cancer cell autophagy. Cancer Lett. 2024;600:217161. https:\/\/doi.org\/10.1016\/j.canlet.2024.217161.","journal-title":"Cancer Lett"},{"issue":"6","key":"556_CR8","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/cdd.2014.201","volume":"22","author":"Y Tian","year":"2015","unstructured":"Tian Y, Kuo CF, Sir D, Wang L, Govindarajan S, Petrovic LM, et al. Autophagy inhibits oxidative stress and tumor suppressors to exert its dual effect on hepatocarcinogenesis. Cell Death Differ. 2015;22(6):1025\u201334. https:\/\/doi.org\/10.1038\/cdd.2014.201.","journal-title":"Cell Death Differ"},{"issue":"1","key":"556_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","volume":"132","author":"B Levine","year":"2008","unstructured":"Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132(1):27\u201342. https:\/\/doi.org\/10.1016\/j.cell.2007.12.018.","journal-title":"Cell"},{"issue":"9","key":"556_CR10","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1158\/1535-7163.MCT-11-0047","volume":"10","author":"ZJ Yang","year":"2011","unstructured":"Yang ZJ, Chee CE, Huang S, Sinicrope FA. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther. 2011;10(9):1533\u201341. https:\/\/doi.org\/10.1158\/1535-7163.MCT-11-0047.","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"556_CR11","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1080\/15548627.2024.2353497","volume":"20","author":"Y Liang","year":"2024","unstructured":"Liang Y, Chen P, Wang S, Cai L, Zhu F, Jiang Y, et al. SCF(FBXW5)-mediated degradation of AQP3 suppresses autophagic cell death through the PDPK1-AKT-MTOR axis in hepatocellular carcinoma cells. Autophagy. 2024;20(9):1984\u201399. https:\/\/doi.org\/10.1080\/15548627.2024.2353497.","journal-title":"Autophagy"},{"issue":"4-5","key":"556_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.drup.2007.05.001","volume":"10","author":"L Moretti","year":"2007","unstructured":"Moretti L, Yang ES, Kim KW, Lu B. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy. Drug Resist Updat. 2007;10(4\u20135):135\u201343. https:\/\/doi.org\/10.1016\/j.drup.2007.05.001.","journal-title":"Drug Resist Updat"},{"issue":"6","key":"556_CR13","doi-asserted-by":"publisher","first-page":"824","DOI":"10.4161\/auto.9099","volume":"5","author":"YT Wu","year":"2009","unstructured":"Wu YT, Tan HL, Huang Q, Ong CN, Shen HM. Activation of the PI3K-Akt-mTOR signaling pathway promotes necrotic cell death via suppression of autophagy. Autophagy. 2009;5(6):824\u201334. https:\/\/doi.org\/10.4161\/auto.9099.","journal-title":"Autophagy"},{"issue":"5","key":"556_CR14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jpha.2023.03.006","volume":"13","author":"L Qu","year":"2023","unstructured":"Qu L, Liu Y, Deng J, Ma X, Fan D. Ginsenoside Rk3 is a novel PI3K\/AKT-targeting therapeutics agent that regulates autophagy and apoptosis in hepatocellular carcinoma. J Pharm Anal. 2023;13(5):463\u201382. https:\/\/doi.org\/10.1016\/j.jpha.2023.03.006.","journal-title":"J Pharm Anal"},{"issue":"8","key":"556_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1856-y","volume":"10","author":"M Zhang","year":"2019","unstructured":"Zhang M, Liu S, Chua MS, Li H, Luo D, Wang S, et al. SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K\/Akt\/mTOR pathway. Cell Death Dis. 2019;10(8):612. https:\/\/doi.org\/10.1038\/s41419-019-1856-y.","journal-title":"Cell Death Dis"},{"issue":"10","key":"556_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1036-5","volume":"9","author":"S Wang","year":"2018","unstructured":"Wang S, Zhu M, Wang Q, Hou Y, Li L, Weng H, et al. Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K\/AKT\/mTOR signalling. Cell Death Dis. 2018;9(10):1027. https:\/\/doi.org\/10.1038\/s41419-018-1036-5.","journal-title":"Cell Death Dis"},{"issue":"12","key":"556_CR17","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1002\/hep4.2019","volume":"6","author":"YC Wang","year":"2022","unstructured":"Wang YC, Tsai MC, Chen YS, Hsieh PM, Hung CM, Lin HY, et al. NPRL2 down-regulation facilitates the growth of hepatocellular carcinoma via the mTOR pathway and autophagy suppression. Hepatol Commun. 2022;6(12):3563\u201377. https:\/\/doi.org\/10.1002\/hep4.2019.","journal-title":"Hepatol Commun"},{"issue":"8","key":"556_CR18","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1002\/cncr.11266","volume":"97","author":"TH Hu","year":"2003","unstructured":"Hu TH, Huang CC, Lin PR, Chang HW, Ger LP, Lin YW, et al. Expression and prognostic role of tumor suppressor gene PTEN\/MMAC1\/TEP1 in hepatocellular carcinoma. Cancer. 2003;97(8):1929\u201340. https:\/\/doi.org\/10.1002\/cncr.11266.","journal-title":"Cancer"},{"issue":"38","key":"556_CR19","doi-asserted-by":"publisher","first-page":"35243","DOI":"10.1074\/jbc.C100319200","volume":"276","author":"S Arico","year":"2001","unstructured":"Arico S, Petiot A, Bauvy C, Dubbelhuis PF, Meijer AJ, Codogno P, et al. The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase\/protein kinase B pathway. J Biol Chem. 2001;276(38):35243\u20136. https:\/\/doi.org\/10.1074\/jbc.C100319200.","journal-title":"J Biol Chem"},{"issue":"6","key":"556_CR20","doi-asserted-by":"publisher","first-page":"873","DOI":"10.4161\/auto.19629","volume":"8","author":"J Xu","year":"2012","unstructured":"Xu J, Wang Y, Tan X, Jing H. MicroRNAs in autophagy and their emerging roles in crosstalk with apoptosis. Autophagy. 2012;8(6):873\u201382. https:\/\/doi.org\/10.4161\/auto.19629.","journal-title":"Autophagy"},{"key":"556_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105133","volume":"161","author":"MH Pourhanifeh","year":"2020","unstructured":"Pourhanifeh MH, Vosough M, Mahjoubin-Tehran M, Hashemipour M, Nejati M, Abbasi-Kolli M, et al. Autophagy-related microRNAs: Possible regulatory roles and therapeutic potential in and gastrointestinal cancers. Pharmacol Res. 2020;161:105133. https:\/\/doi.org\/10.1016\/j.phrs.2020.105133.","journal-title":"Pharmacol Res"},{"issue":"1","key":"556_CR22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.7150\/ijbs.50773","volume":"17","author":"C Shan","year":"2021","unstructured":"Shan C, Chen X, Cai H, Hao X, Li J, Zhang Y, et al. The Emerging Roles of Autophagy-Related MicroRNAs in Cancer. Int J Biol Sci. 2021;17(1):134\u201350. https:\/\/doi.org\/10.7150\/ijbs.50773.","journal-title":"Int J Biol Sci"},{"issue":"4","key":"556_CR23","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","volume":"136","author":"RW Carthew","year":"2009","unstructured":"Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell. 2009;136(4):642\u201355. https:\/\/doi.org\/10.1016\/j.cell.2009.01.035.","journal-title":"Cell"},{"issue":"9","key":"556_CR24","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrg2843","volume":"11","author":"J Krol","year":"2010","unstructured":"Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010;11(9):597\u2013610. https:\/\/doi.org\/10.1038\/nrg2843.","journal-title":"Nat Rev Genet"},{"issue":"7","key":"556_CR25","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1080\/15548627.2020.1781368","volume":"17","author":"Q Zhu","year":"2021","unstructured":"Zhu Q, Zhang Q, Gu M, Zhang K, Xia T, Zhang S, et al. MIR106A-5p upregulation suppresses autophagy and accelerates malignant phenotype in nasopharyngeal carcinoma. Autophagy. 2021;17(7):1667\u201383. https:\/\/doi.org\/10.1080\/15548627.2020.1781368.","journal-title":"Autophagy"},{"issue":"1","key":"556_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13045-018-0618-0","volume":"11","author":"H Li","year":"2018","unstructured":"Li H, Chen L, Li JJ, Zhou Q, Huang A, Liu WW, et al. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3\/Bcl2 signaling pathway. J Hematol Oncol. 2018;11(1):70. https:\/\/doi.org\/10.1186\/s13045-018-0618-0.","journal-title":"J Hematol Oncol"},{"key":"556_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110566","volume":"103","author":"Y Shi","year":"2023","unstructured":"Shi Y, Wang J, Tao S, Zhang S, Mao L, Shi X, et al. MiR-142-3p improves paclitaxel sensitivity in resistant breast cancer by inhibiting autophagy through the GNB2-AKT-mTOR pathway. Cell Signal. 2023;103:110566. https:\/\/doi.org\/10.1016\/j.cellsig.2022.110566.","journal-title":"Cell Signal"},{"issue":"2","key":"556_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/s0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281\u201397. https:\/\/doi.org\/10.1016\/s0092-8674(04)00045-5.","journal-title":"Cell"},{"issue":"5","key":"556_CR29","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3322\/caac.21244","volume":"64","author":"I Berindan-Neagoe","year":"2014","unstructured":"Berindan-Neagoe I, Monroig PC, Pasculli B, Calin GA. MicroRNAome genome: a treasure for cancer diagnosis and therapy. CA Cancer J Clin. 2014;64(5):311\u201336. https:\/\/doi.org\/10.3322\/caac.21244.","journal-title":"CA Cancer J Clin"},{"key":"556_CR30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev.pathol.4.110807.092222","volume":"4","author":"YS Lee","year":"2009","unstructured":"Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009;4:199\u2013227. https:\/\/doi.org\/10.1146\/annurev.pathol.4.110807.092222.","journal-title":"Annu Rev Pathol"},{"issue":"11","key":"556_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e11503","volume":"8","author":"H Peng","year":"2022","unstructured":"Peng H, Hou M, Wu Z, Wang J, Zhou M, Zhuang X, et al. Plasma exosomal miR-122 regulates the efficacy of metformin via AMPK in type 2 diabetes and hepatocellular carcinoma. Heliyon. 2022;8(11):e11503. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e11503.","journal-title":"Heliyon"},{"issue":"9","key":"556_CR32","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S2468-1253(19)30178-5","volume":"4","author":"J Lu","year":"2019","unstructured":"Lu J, Zhang XP, Zhong BY, Lau WY, Madoff DC, Davidson JC, et al. Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west. Lancet Gastroenterol Hepatol. 2019;4(9):721\u201330. https:\/\/doi.org\/10.1016\/S2468-1253(19)30178-5.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"556_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.genom.7.080505.115623","volume":"7","author":"GA Maston","year":"2006","unstructured":"Maston GA, Evans SK, Green MR. Transcriptional regulatory elements in the human genome. Annu Rev Genomics Hum Genet. 2006;7:29\u201359. https:\/\/doi.org\/10.1146\/annurev.genom.7.080505.115623.","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"4","key":"556_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.0030067","volume":"3","author":"J Lee","year":"2007","unstructured":"Lee J, Li Z, Brower-Sinning R, John B. Regulatory circuit of human microRNA biogenesis. PLoS Comput Biol. 2007;3(4):e67. https:\/\/doi.org\/10.1371\/journal.pcbi.0030067.","journal-title":"PLoS Comput Biol"},{"key":"556_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.canlet.2018.04.010","volume":"427","author":"CJ Stavast","year":"2018","unstructured":"Stavast CJ, Leenen PJM, Erkeland SJ. The interplay between critical transcription factors and microRNAs in the control of normal and malignant myelopoiesis. Cancer Lett. 2018;427:28\u201337. https:\/\/doi.org\/10.1016\/j.canlet.2018.04.010.","journal-title":"Cancer Lett"},{"issue":"8","key":"556_CR36","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1182\/blood-2014-06-581892","volume":"125","author":"L Shaham","year":"2015","unstructured":"Shaham L, Vendramini E, Ge Y, Goren Y, Birger Y, Tijssen MR, et al. MicroRNA-486-5p is an erythroid oncomiR of the myeloid leukemias of Down syndrome. Blood. 2015;125(8):1292\u2013301. https:\/\/doi.org\/10.1182\/blood-2014-06-581892.","journal-title":"Blood"},{"issue":"12","key":"556_CR37","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1038\/cdd.2015.30","volume":"22","author":"E Bianchi","year":"2015","unstructured":"Bianchi E, Bulgarelli J, Ruberti S, Rontauroli S, Sacchi G, Norfo R, et al. MYB controls erythroid versus megakaryocyte lineage fate decision through the miR-486-3p-mediated downregulation of MAF. Cell Death Differ. 2015;22(12):1906\u201321. https:\/\/doi.org\/10.1038\/cdd.2015.30.","journal-title":"Cell Death Differ"},{"issue":"1","key":"556_CR38","doi-asserted-by":"publisher","first-page":"e417","DOI":"10.1038\/emm.2017.158","volume":"50","author":"Z Xu","year":"2018","unstructured":"Xu Z, Hu J, Cao H, Pilo MG, Cigliano A, Shao Z, et al. Loss of Pten synergizes with c-Met to promote hepatocellular carcinoma development via mTORC2 pathway. Exp Mol Med. 2018;50(1):e417. https:\/\/doi.org\/10.1038\/emm.2017.158.","journal-title":"Exp Mol Med"},{"issue":"3","key":"556_CR39","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"556_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02101-z","volume":"23","author":"YT Chan","year":"2024","unstructured":"Chan YT, Zhang C, Wu J, Lu P, Xu L, Yuan H, et al. Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma. Mol Cancer. 2024;23(1):189. https:\/\/doi.org\/10.1186\/s12943-024-02101-z.","journal-title":"Mol Cancer"},{"issue":"2","key":"556_CR41","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000367754","volume":"5","author":"LC Lu","year":"2016","unstructured":"Lu LC, Hsu CH, Hsu C, Cheng AL. Tumor heterogeneity in hepatocellular carcinoma: facing the challenges. Liver Cancer (Basel). 2016;5(2):128\u201338. https:\/\/doi.org\/10.1159\/000367754.","journal-title":"Liver Cancer (Basel)"},{"key":"556_CR42","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.semcancer.2021.02.015","volume":"82","author":"LK Chan","year":"2022","unstructured":"Chan LK, Tsui YM, Ho DW, Ng IO. Cellular heterogeneity and plasticity in liver cancer. Semin Cancer Biol. 2022;82:134\u201349. https:\/\/doi.org\/10.1016\/j.semcancer.2021.02.015.","journal-title":"Semin Cancer Biol"},{"issue":"32","key":"556_CR43","doi-asserted-by":"publisher","first-page":"52948","DOI":"10.18632\/oncotarget.17635","volume":"8","author":"SJ Fu","year":"2017","unstructured":"Fu SJ, Chen J, Ji F, Ju WQ, Zhao Q, Chen MG, et al. MiR-486-5p negatively regulates oncogenic NEK2 in hepatocellular carcinoma. Oncotarget. 2017;8(32):52948\u201359. https:\/\/doi.org\/10.18632\/oncotarget.17635.","journal-title":"Oncotarget"},{"issue":"4","key":"556_CR44","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.3892\/ol.2016.4914","volume":"12","author":"RA Youness","year":"2016","unstructured":"Youness RA, El-Tayebi HM, Assal RA, Hosny K, Esmat G, Abdelaziz AI. MicroRNA-486-5p enhances hepatocellular carcinoma tumor suppression through repression of IGF-1R and its downstream mTOR, STAT3 and c-Myc. Oncol Lett. 2016;12(4):2567\u201373. https:\/\/doi.org\/10.3892\/ol.2016.4914.","journal-title":"Oncol Lett"},{"issue":"1","key":"556_CR45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s43018-023-00672-2","volume":"5","author":"Z Li","year":"2024","unstructured":"Li Z, Pai R, Gupta S, Currenti J, Guo W, Di Bartolomeo A, et al. Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy. Nat Cancer. 2024;5(1):167\u201386. https:\/\/doi.org\/10.1038\/s43018-023-00672-2.","journal-title":"Nat Cancer"},{"key":"556_CR46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-med-052218-125823","volume":"71","author":"L Yehia","year":"2020","unstructured":"Yehia L, Keel E, Eng C. The clinical spectrum of PTEN mutations. Annu Rev Med. 2020;71:103\u201316. https:\/\/doi.org\/10.1146\/annurev-med-052218-125823.","journal-title":"Annu Rev Med"},{"issue":"1","key":"556_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22(1):138. https:\/\/doi.org\/10.1186\/s12943-023-01827-6.","journal-title":"Mol Cancer"},{"key":"556_CR48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","volume":"85","author":"L Yu","year":"2022","unstructured":"Yu L, Wei J, Liu P. Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Semin Cancer Biol. 2022;85:69\u201394. https:\/\/doi.org\/10.1016\/j.semcancer.2021.06.019.","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"556_CR49","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13(2):132\u201341. https:\/\/doi.org\/10.1038\/ncb2152.","journal-title":"Nat Cell Biol"},{"issue":"12","key":"556_CR50","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1038\/bjc.2015.400","volume":"113","author":"SK Srivastava","year":"2015","unstructured":"Srivastava SK, Bhardwaj A, Arora S, Singh S, Azim S, Tyagi N, et al. MYB is a novel regulator of pancreatic tumour growth and metastasis. Br J Cancer. 2015;113(12):1694\u2013703. https:\/\/doi.org\/10.1038\/bjc.2015.400.","journal-title":"Br J Cancer"},{"issue":"1","key":"556_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-29-172","volume":"29","author":"RX Chen","year":"2010","unstructured":"Chen RX, Xia YH, Xue TC, Ye SL. Transcription factor c-Myb promotes the invasion of hepatocellular carcinoma cells via increasing osteopontin expression. J Exp Clin Cancer Res. 2010;29(1):172. https:\/\/doi.org\/10.1186\/1756-9966-29-172.","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"556_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.464","volume":"11","author":"L Zhang","year":"2021","unstructured":"Zhang L, Wang X, Li Y, Han J, Gao X, Li S, et al. c-Myb facilitates immune escape of esophageal adenocarcinoma cells through the miR-145-5p\/SPOP\/PD-L1 axis. Clin Transl Med. 2021;11(9):e464. https:\/\/doi.org\/10.1002\/ctm2.464.","journal-title":"Clin Transl Med"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00556-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00556-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00556-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:15:11Z","timestamp":1787552111000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-026-00556-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["556"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00556-8","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"4 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Plasma specimens were obtained from 19 patients diagnosed with hepatocellular carcinoma (HCC) and 6 healthy volunteer donors at the Eastern Hepatobiliary Surgery Hospital (EHBH), Shanghai, China. This investigation was conducted in compliance with the ethical principles outlined in the Declaration of Helsinki. The study protocol was reviewed and formally approved by the Ethics Committee of EHBH (approval No. EHBHKY2018-1\u2013001). Animal procedures were approved by the Animal Ethics Committee of The First Affiliated Hospital of USTC (Approval No. 2024-N(A)-0374) and conducted in accordance with relevant guidelines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"148"}}